U.S. markets closed

OptimizeRx Corporation (OPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
61.41+3.98 (+6.93%)
At close: 4:00PM EDT
61.40 -0.01 (-0.02%)
After hours: 04:38PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close57.43
Open58.08
Bid61.15 x 900
Ask61.41 x 1100
Day's Range58.08 - 61.45
52 Week Range12.69 - 63.98
Volume320,459
Avg. Volume175,064
Market Cap1.061B
Beta (5Y Monthly)0.63
PE Ratio (TTM)N/A
EPS (TTM)-0.05
Earnings DateAug 03, 2021 - Aug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est74.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • OptimizeRx Aligned With Pharma Across Fast Growing Specialty Therapeutic Areas
    GlobeNewswire

    OptimizeRx Aligned With Pharma Across Fast Growing Specialty Therapeutic Areas

    Continued focus on building and closing pipeline of enterprise solutions across oncology, cardiology and immunologyROCHESTER, Mich., June 15, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, discusses aspects of the Company’s 2021 strategic operating plan which has been aligned with the pharma industry’s market sizing opportunity across fast growing specialty therapeutic a

  • OptimizeRx Named to LD Micro’s “Hall of Fame” As One of the Top 50 Performing Companies
    GlobeNewswire

    OptimizeRx Named to LD Micro’s “Hall of Fame” As One of the Top 50 Performing Companies

    ROCHESTER, Mich., June 01, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo, OptimizeRx’s CEO, will participate in the LD Micro Virtual Invitational (XI) conference on June 8, 2021. OptimizeRx will be inducted into LD Micro’s “Hall of Fame”, ranked number 36 of 50. The LD Micro Hall of Fame list highlights the top 50 best performing companies out of over 2,000 companies which have attended prior LD Micro conferences. The live webcast and replay of the presentation will be made available on the day of the event at investors.optimizerx.com/events-and-presentations. Conference details (LD Micro Virtual Invitational (XI))Date:Tuesday, June 8Time:3:00-3:25 PM ETTrack:Track 1 LD Micro’s three-day virtual investor conference will feature around 180 companies presenting for 25 minutes each and several influential keynotes. You can register for the event here: https://ldmicrojune2021.mysequire.com. About OptimizeRxOptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary network, the OptimizeRx digital health platform helps patients afford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along the patient journey, from point-of-care, to retail pharmacy, through mobile patient engagement. For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com. Important Cautions Regarding Forward-Looking Statements This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and in section 21E of the Securities and Exchange Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks. OptimizeRx ContactDoug Baker, CFOTel (248) 651-6568 x807dbaker@optimizerx.com Media Relations Contact Maira Alejandra, Media Relations ManagerTel (754) 245-7070 malejandra@optimizerx.com Investor Relations ContactAshley RobinsonLifeSci Advisors, LLCarr@lifesciadvisors.com

  • OptimizeRx to Participate in the William Blair 41st Annual Growth Stock Conference
    GlobeNewswire

    OptimizeRx to Participate in the William Blair 41st Annual Growth Stock Conference

    ROCHESTER, Mich., May 25, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo, OptimizeRx’s, CEO will participate in a fireside chat at the William Blair 41st Annual Growth Stock Conference. The live webcast and replay of the presentation will be made available on the day of the event at investors.optimizerx.com/events-and-presentations. Conference Details: William Blair' s 41st Annual Growth Stock ConferenceLocation: Virtual 2Date:Wednesday, June 2Time: 9:20-9:50 AM CT / 10:20-10:50 AM ET About OptimizeRxOptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary network, the OptimizeRx digital health platform helps patients afford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along the patient journey, from point-of-care, to retail pharmacy, through mobile patient engagement. For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com. Important Cautions Regarding Forward-Looking Statements This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and in section 21E of the Securities and Exchange Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks. OptimizeRx ContactDoug Baker, CFOTel (248) 651-6568 x807dbaker@optimizerx.com Media Relations Contact Maira Alejandra, Media Relations ManagerTel (754) 245-7070 malejandra@optimizerx.com Investor Relations ContactAshley RobinsonLifeSci Advisors, LLCarr@lifesciadvisors.com